Moreover, our finding that aplidine is active on VEGF- and FGF-stimulated endothelial cells suggests that the compound might indeed affect the endothelium of tumour vessels, exposed to an environment rich in angiogenic and proliferating stimuli. Here, VEGFA is linked to neoplasm.